Category: Pharmaceuticals
New Zealand Pharmaceuticals
-
2024 New Zealand Hematology and Flow Cytometry Database: Analyzers and Reagents, Supplier Shares, Test Volume and Sales Forecasts
... hematology and flow cytometry tests, including: Hematology Tests CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils Flow ... Read More
-
Asia-Pacific Omega-3 Supplements Market, By Source (Fish Oil, Krill Oil, Algae Oil, Others), By Form (Tablets, Capsules, Soft Gels, Others), By Functionality (Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, Others), By End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, ... Read More
-
Australia And New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029). Key Highlights A holistic study of the market studied has been carried out ... Read More
-
New Zealand Insulin Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 552.60 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The ... Read More
-
New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients ... Read More
-
New Zealand Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 872.63 million by 2029, growing at a CAGR of 4% during the forecast period (2024-2029). Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and ... Read More
-
New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 512.09 million by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029). An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If ... Read More
-
Australia and New Zealand Anemia in Pregnancy Market Report and Forecast 2024-2032
... and New Zealand anemia in pregnancy market size is anticipated to grow at a CAGR of 8.6% during the forecast period of 2024-2032, driven by the rising incidence of pregnancies across the region. Anemia in ... Read More
-
Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032
... and New Zealand cutaneous T-cell lymphoma market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032, driven by the increasing prevalence of the condition and the development of ... Read More
-
Australia and New Zealand Endotoxin Testing Market Report and Forecast 2024-2032
... endotoxin testing market size is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032, driven by the increase in development of innovative, rapid, and sensitive testing methods. Endotoxin Testing: Introduction ... Read More
-
Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029
... End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, Asia ... Read More
-
Australia & New Zealand Cannabis Extraction & Analytical Testing Market Forecast 2023-2030
... the forecast years, 2023 to 2030. Australia is one of the largest importers of unapproved medical cannabis products, as well as cannabis for scientific purposes worldwide, along with Israel and Germany. MARKET INSIGHTS In Australia, ... Read More
-
2023-2027 New Zealand Clinical Chemistry and Immunodiagnostic Analyzers and Reagents-Supplier Shares, Volume and Sales Segment Forecasts for 100 Tests -Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays-High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... Growth Strategies, Latest Technologies and Instrumentation Pipeline Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch. Read More
-
2023-2027 New Zealand Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ... Read More
-
Australia and New Zealand Healthcare CROs Market Report and Forecast 2024-2032
... driven by increasing complexity of clinical trials, rising R&D costs, the need for specialized expertise, and the focus on accelerating drug development. The market size is anticipated to grow at a CAGR of 11.9% during ... Read More
-
Australia And New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion in 2023 to USD 1.27 billion by 2028, at a CAGR of 2.70% during the forecast period (2023-2028). Key Highlights A holistic study of the market studied has been carried out by incorporating various ... Read More
-
New Zealand Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 357.92 million by 2028, at a CAGR of 2.60% during the forecast period (2023-2028). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients and older adult ... Read More
-
New Zealand Insulin Drugs And Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... million in 2023 to USD 546.59 million by 2028, at a CAGR of 1.10% during the forecast period (2023-2028). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The largest risk was ... Read More
-
New Zealand Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 839.07 million by 2028, at a CAGR of 4% during the forecast period (2023-2028). Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and older adult patients ... Read More
-
New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 495.73 million by 2028, at a CAGR of 3.30% during the forecast period (2023-2028). An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If they get COVID-19, ... Read More
-
Australia & New Zealand Herbal Supplements Market, By Foam (Tablets, Capsules, Powder, and Liquid), By Product (Beauty Supplement, Bone and Joint Supplement, Body Building Supplement, Digestive & Heart Supplement, Immunity Supplement, Brain Supplement, Weight Loss Supplement, and Others (Vision Supplement, Menopause Supplement))- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Supplement, and Others (Vision Supplement, Menopause Supplement))- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Herbal supplements are botanical based nutritional supplements that are consumed to avoid the nutritional deficiency in diet. Rising number ... Read More
-
Global Carbon Credit (Compliance & Voluntary) Market: Analysis By Traded Value, By Traded Volume, By Segment (Europe, North America, UK ETS, New Zealand, South Korea, China, and CERs), By Project Category (Forestry and Land Use, Renewable Energy, Chemical Process/Industrial Manufacturing, Household/Community Devices, Waste Disposal, Energy Efficiency/ Fuel Switching, Agriculture, and Transportation), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... Renewable Energy, Chemical Process/Industrial Manufacturing, Household/Community Devices, Waste Disposal, Energy Efficiency/ Fuel Switching, Agriculture, and Transportation), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 The global carbon credit market ... Read More
-
New Zealand Insulin Drugs and Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)���
... of more than 4%. After COVID-19 was detected, the risk of developing type 1 diabetes increased. The largest risk was in young pediatric and older adult patients with COVID-19. Type 1 diabetic patients were more ... Read More
-
New Zealand Diabetes Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If they get COVID-19, a diabetic patient will likely develop a serious illness and may even pass away. Diabetes ... Read More
-
Australia and New Zealand Industrial Flooring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... during the forecast period. Key Highlights COVID-19 negatively impacted the market in 2020. The building and construction industry came to a standstill owing to the unavailability of raw materials, shortage of laborers, and disruption in ... Read More
Research Assistance
